Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer
1117.5000 5.50 (0.49%)
NSE Oct 09, 2026 15:31 PM
Volume: 529.8K
 

logo
Zydus Lifesciences Ltd.
21 Nov 2019
1117.50
0.49%
Business Line
Cadila Healthcare said it has received approval from the US health regulator to market Isosorbide Dinitrate tablets used to prevent attacks of chest p
Zydus Lifesciences L.. has an average target of 1075.00 from 4 brokers.
USFDA approves Zydus Cadila's Dinitrate tablets, Desonide Cream
Business Line | 21 Nov 2019 1 more
More from Zydus Lifesciences Ltd.
Recommended
Five Interesting Stocks Today - October 9, 2026
The Baseline | 09 Oct 2026, 06:08PM
Market closes higher as IT stocks gain following TCS’ Q2 results
Trendlyne Marketwatch | 09 Oct 2026, 04:15PM
Earnings Call Transcript - Cadila Healthcare
| 14 Feb 2020